13 April 2023
Headlam Group plc
(the 'Company')
Grant of awards under Deferred Bonus Plan ('DBP')
As detailed in the 2022 Annual Report and Accounts, under the DBP, one-third of any annual bonus amount awarded to Executive Directors is required to be deferred into a right to acquire ordinary shares in the Company at nil-cost. Following payment of the annual bonus in respect of the financial year ended 31 December 2022, on 13 April 2023, the Company granted nil-cost options to the following Executive Director:
Executive Director / PDMR
|
Role |
Amount of Bonus Deferred (£) |
Number of ordinary shares over which options granted |
Chris Payne
|
Chief Executive |
67,940 |
22,563 |
The 2023 DBP option will not vest until the second anniversary of the grant date, and is subject to a dividend equivalent in the form of shares, calculated on a re-investment basis. The number of ordinary shares over which the option was granted was calculated based on a share price of 301.1 pence per ordinary share, being the average mid-market closing share price for the five business days prior to the grant date, as derived from the London Stock Exchange daily official list.
Headlam Group plc | Tel: 01675 433 000 |
Chris Payne, Chief Executive | Email: headlamgroup@headlam.com |
Catherine Miles, Director of IR and ESG | |
Panmure Gordon (UK) Limited (Corporate Broker) | Tel: 020 7886 2500 |
Tom Scrivens / Atholl Tweedie
Peel Hunt LLP (Corporate Broker) |
Tel: 020 7418 8900 |
George Sellar / John Welch
| |
| |
Notification and public disclosure of transactions by persons discharging managerial
responsibilities / persons closely associated with them.
1. | Details of PDMR / person closely associated with them ("PCA") | |||||
a) | Name | Chris Payne | ||||
2. | Reason for the notification | |||||
a) | Position / status | Chief Executive | ||||
b) | Initial notification / amendment | Initial notification | ||||
3. | Details of the issuer | |||||
a) | Name | Headlam Group plc | ||||
b) | LEI | 213800I4AZZUJEYX9O90 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument | Ordinary shares of £0.05 each. | ||||
b) | Identification code | ISIN: GB0004170089 | ||||
c) | Nature of the transaction | Grant of nil-cost options over Ordinary Shares under the Company's Deferred Bonus Plan | ||||
d) | Price(s) and volume(s) |
| ||||
e) | Aggregated information - Volume - Price | N/A | ||||
f) | Date of the transaction | 13 April 2023 | ||||
g) | Place of the transaction | Outside a trading venue |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.